LSX Nordic Congress-1


 29-30 AUGUST 2018 | NASDAQ OFFICE | STOCKHOLM

DOWNLOAD THE BROCHURE
BOOK YOUR TICKET NOW

2018 Event Partners

ABOUT THE 2018 Nordic Congress


The LSX Nordic Congress is a high-calibre, senior executive conference and partnering event providing the education, strategies, solutions, and contacts that life science companies need to enable more effective investment, business planning and partnering within their businesses.

The Nordic region has long produced world-leading science and innovation and Nasdaq Nordic is one of the leading hubs for biotech companies in Europe, strengthened further by a hugely active IPO market over the last two years. However, growth and venture funding is lacking compared with other hubs and listed Nordic companies face a number of specific challenges in their ongoing funding, growth, development and internationalisation.

With our relentless focus on quality peer-to-peer discussion, high-level networking and partnering, unique formats and a vetted, high-calibre audience, we will bring together the people that matter to the future of life sciences in the Nordic region to address these challenges and work towards actionable outcomes to help it flourish.

LEARN MORE

 

SATELLITE AND ANCILLARY FORUMS

                     LSX Nordic Final.png                           CEO Forum-2.png                              Investable-4.png                     IPO Bootcamp 2018.png

        VIEW THE ADVANCED BROCHURE FOR:

                                                          Provisional Agenda and Invited Speakers
                                                           Ancillary Forums and Events
                                                          Reasons To Attend
                                                          

DOWNLOAD THE BROCHURE

Nordic Congress Download Brochure.png

CONFIRMED SPEAKERS

Viktor Drvota

Viktor Drvota
CEO, Karolinska Development

Peter Benson

Peter Benson
Managing Partner, Sunstone Capital

Ingrid Teigland

Ingrid Teigland Akay
Managing Partner, Hadean Ventures

Christine Lind

Christine Lind
President and CEO, Medivir AB

Adam Kostyál

Adam Kostyál
SVP, Listing Service, Europe, Nasdaq

Kasim Kutay

Kasim Kutay
CEO, Novo Holdings

Per Andersson

Per Andersson
CEO, Xspray

Nina Rawal, Head of Life Sciences, Industrifonden

Nina Rawal
Head of Life Sciences, Industrifonden

Åsa Riisberg

Åsa Riisberg
Partner and Head of Healthcare Sector, EQT Partners

Ragnar Hellenius

Ragnar Hellenius
Partner, PAI Partners

Mårten Steen, Partner, HealthCap

Mårten Steen
Partner, HealthCap

Jan-Olof Jacke

Jan-Olof Jacke
CEO/President, AstraZeneca AB

Nathalie ter Wengel

Nathalie ter Wengel
European Head External R&D and Innovation, Pfizer

 Julie Silber, Managing Partner, The Blueshirt Group

Julie Silber
Managing Partner, The Blueshirt Group

Mats Blom

Mats Blom
CFO, Zealand Pharma

Ulrica Slåne Bjerke

Ulrica Slåne Bjerke
Founder & CIO, Arctic Aurora LifeScience

Jenni Nordborg

Jenni Nordborg
National Coordinator Life Sciences, Government Offices of Sweden

Miriam Frieden

Miriam Frieden
Vice President R&D Innovation Sourcing, Novo Nordisk

Don deBethizy

Don deBethizy
Chairman, Saniona

Nikolaj Sørensen

Nikolaj Sørensen
CEO, Orexo

Rasmus Beedholm-Ebsen,

Rasmus Beedholm-Ebsen
Senior Advisor - Life Sciences, Invest in Denmark, Ministry of Foreign Affairs of Denmark

OFFICIAL EVENT PARTNER

Nasdaq17_313+BK.png                 

 PREVIOUS NORDIC CLIENTS AND PARTNERS

Previous Nordic Companies.png

2018 EVENT VENUE

Address: 

Nasdaq Stockholm
Tullvaktsvägen 15, 105 78 Stockholm, Sweden

CONTACT US

Address : Suite 125, The Business Design Centre, 52 Upper St, London, N1 0QH, UK

Email: info@biotechandmoney.com

Phone: +44 (0) 203 637 5908